Valuation: Alkem Laboratories Limited

Market Cap 642B 6.73B 5.76B 5.39B 4.93B 9.3B 9.39B 63.6B 24.78B 324B 25.26B 24.71B 1,071B P/E 2027 *
28x
P/E 2028 * 24.3x
Enterprise Value 629B 6.59B 5.64B 5.28B 4.83B 9.11B 9.2B 62.3B 24.28B 317B 24.74B 24.2B 1,049B EV / Sales 2027 *
3.77x
EV / Sales 2028 * 3.3x
Free-Float
37.56%
Yield 2027 *
0.92%
Yield 2028 * 1.03%
1 day+0.34%
1 week-0.11%
Current month-6.67%
1 month-4.71%
3 months-0.68%
6 months-2.32%
Current year-2.52%
1 week 5,297
Extreme 5297
5,489.5
1 month 5,175
Extreme 5175
5,882.5
Current year 5,075
Extreme 5075
5,933.5
1 year 5,075
Extreme 5075
5,933.5
3 years 3,447
Extreme 3447
6,439.9
5 years 2,828
Extreme 2828
6,439.9
10 years 1,455
Extreme 1455
6,439.9
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 01/02/2024
Director TitleAgeSince
Director/Board Member 44 09/08/2013
Director/Board Member 63 11/02/2008
Director/Board Member 45 11/11/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%-0.11%-1.07%+44.49% 6.68B
-1.06%+4.27%+73.34%+125.12% 1,111B
+0.53%+4.10%+52.35%+65.45% 658B
+0.48%+6.18%+26.21%+81.27% 467B
+0.92%+4.97%+42.94%+43.69% 369B
+1.25%+4.00%+25.87%+42.82% 301B
+3.02%+7.92%+4.24%+16.06% 256B
-0.36%+5.45%+50.57%+72.33% 240B
+2.86%+5.27%-15.42%-52.34% 207B
+1.38%+7.09%+29.62%+94.90% 182B
Average +1.06%+4.00%+28.87%+53.38% 379.77B
Weighted average by Cap. +1.04%+4.67%+44.04%+73.02%

Financials

2027 *2028 *
Net sales 167B 1.75B 1.5B 1.4B 1.28B 2.42B 2.44B 16.55B 6.45B 84.19B 6.57B 6.43B 279B 186B 1.95B 1.67B 1.56B 1.43B 2.69B 2.72B 18.4B 7.17B 93.62B 7.31B 7.15B 310B
Net income 23.14B 243M 208M 194M 178M 336M 339M 2.29B 894M 11.67B 911M 891M 38.63B 27.15B 285M 244M 228M 209M 394M 397M 2.69B 1.05B 13.69B 1.07B 1.05B 45.32B
Net Debt -13.08B -137M -117M -110M -100M -190M -191M -1.3B -505M -6.59B -515M -504M -21.83B -28.06B -294M -252M -236M -216M -407M -411M -2.78B -1.08B -14.14B -1.1B -1.08B -46.83B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
25/08/26 INR 5,368.00 +0.34% 48,065
24/08/26 INR 5,350.00 -0.93% 46,339
21/08/26 INR 5,400.00 0.00% 76,854
20/08/26 INR 5,400.00 +0.33% 85,369
19/08/26 INR 5,382.50 -1.69% 213,076
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,368.00INR
Average target price
5,948.55INR
Spread / Average Target
+10.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALKEM Stock